Search Results 421-430 of 17978 for what is vedolizumab

  1. Frequent bowel movements Causes - Mayo Clinic

    Celiac disease · Crohn's disease — which causes tissues in the digestive tract to become inflamed. Ulcerative colitis — a disease that causes ulcers and ...

  2. A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) - Mayo Clinic

    A Study to Evaluate Effectiveness and Safety of Ustekinumab Re-induction Therapy in Participants With Moderate to Severely Active Crohn's Disease (POWER) · Share ...

  3. Early Mayo Clinic research finds hope in stem cell therapy for perianal fistulas in patients with Crohn's disease

    As many as 26% of people with Crohn's disease will develop perianal fistulas. Most often, it starts with an infection within the anal gland and often progresses ...

  4. Immuno-Epigenetics: William A. Faubion Jr.

    ... Crohn's disease and ulcerative colitis. Epigenetics is the study of the heritable changes to gene expression without changing the DNA code. Environmental ...

  5. Abdominal pain - Mayo Clinic

    Crohn's Crisis · Crohn's disease · Crohn's disease and the gut microbiome · What is Crohn's disease? A Mayo Clinic expert explains · Crohn's or Colitis · Cyclic ...

  6. Mayo Clinic Q and A: Treatment for a parastomal hernia

    ANSWER: Occasionally, the surgical treatment of Crohn's disease, ulcerative colitis and other gastrointestinal, gynecologic, or urologic conditions, both ...

  7. Patients with Inflammatory Bowel Disease Have Higher Risk of Melanoma - Mayo Clinic News Network

    More than 1.5 million Americans have Crohn's disease or ulcerative colitis, the most common forms of inflammatory bowel disease. Both conditions inflame the ...

  8. A Study to Evaluate the Long-Term Safety and Effectiveness of Upadacitinib (ABT-494) in Subjects with Ulcerative Colitis (UC) - Mayo Clinic

    This study is designed to evaluate the long-term safety and efficacy of ABT-494 in participants with ulcerative colitis (UC) who have not responded at the end ...

  9. Pyoderma gangrenosum - Symptoms and causes - Mayo Clinic

    It's often seen in people who have autoimmune diseases, such as ulcerative colitis, Crohn's disease and arthritis. And some studies suggest that it may be ...

  10. A Study to Evaluate the Accuracy of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation ... vedolizumab within 8 weeks prior to first golimumab administration; ...